PICTON MAHONEY ASSET MANAGEMENT - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
PICTON MAHONEY ASSET MANAGEMENT ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$161,000
-56.6%
6,400
-57.3%
0.01%
-48.0%
Q3 2016$371,000
+23.3%
15,000
+1.4%
0.02%
+31.6%
Q2 2016$301,000
-55.7%
14,800
-70.7%
0.02%
-53.7%
Q4 2015$679,000
-35.7%
50,500
-32.9%
0.04%
-32.8%
Q3 2015$1,056,00075,3000.06%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders